These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7726503)

  • 21. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins?
    Pechère JC
    Scand J Infect Dis Suppl; 1991; 78():17-21. PubMed ID: 1658922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.
    Quinn JP; Dudek EJ; DiVincenzo CA; Lucks DA; Lerner SA
    J Infect Dis; 1986 Aug; 154(2):289-94. PubMed ID: 3088133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in carbapenems.
    Bonfiglio G; Russo G; Nicoletti G
    Expert Opin Investig Drugs; 2002 Apr; 11(4):529-44. PubMed ID: 11922861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
    Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
    Dib C; Trias J; Jarlier V
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Fernández-Cuenca F; Martínez-Martínez L; Conejo MC; Ayala JA; Perea EJ; Pascual A
    J Antimicrob Chemother; 2003 Mar; 51(3):565-74. PubMed ID: 12615856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ; Drusano GL; Mobley HL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1892-6. PubMed ID: 3125787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
    Chambers HF
    Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of meropenem, against gram-positive bacteria.
    Kayser FH; Morenzoni G; Strässle A; Hadorn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate.
    Bellido F; Veuthey C; Blaser J; Bauernfeind A; Pechère JC
    J Antimicrob Chemother; 1990 Jan; 25(1):57-68. PubMed ID: 2108115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.
    Livermore DM
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2046-8. PubMed ID: 1329641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.
    Raimondi A; Traverso A; Nikaido H
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1174-80. PubMed ID: 1656855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
    Kresken M; Körber-Irrgang B; Korte-Berwanger M; Pfennigwerth N; Gatermann SG; Seifert H;
    Int J Antimicrob Agents; 2020 Jun; 55(6):105959. PubMed ID: 32325200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa.
    Livermore DM
    J Med Microbiol; 1984 Oct; 18(2):261-70. PubMed ID: 6092639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.
    Fukuoka T; Ohya S; Narita T; Katsuta M; Iijima M; Masuda N; Yasuda H; Trias J; Nikaido H
    Antimicrob Agents Chemother; 1993 Feb; 37(2):322-7. PubMed ID: 8452364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.